Trump administration's embattled FDA vaccine chief is leaving for the second time

The FDA's controversial vaccine chief, Dr. Vinay Prasad, is leaving the agency. It's the second time he has abruptly departed ...
Becker's Hospital Review

The Trump administration’s drug pricing deals, explained

In the closing months of 2025, President Donald Trump’s effort to reshape how Americans pay for prescription drugs has taken clearer form. What started as a campaign threat to slap tariffs on ...
CURE

Iberdomide and the Rise of CELMoDs in Multiple Myeloma

The landscape of relapsed or refractory multiple myeloma (RRMM) treatment is shifting toward a more targeted future. Recently ...

FDA will drop two-study requirement for new drug approvals, aiming to speed access

The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous studies for new drug approvals ...
Forbes

Trump Administration Unveils Details On Most-Favored Nation Prices For Drugs

WASHINGTON, DC - SEPTEMBER 30: U.S. President Donald Trump shakes hands with Pfizer CEO Albert Bourla (L) as he announces a deal with the company to lower Medicaid drug prices and to sell certain ...

FDA cracks down on weight-loss drug alternatives as thousands sickened in Maryland

BALTIMORE — Popular weight-loss drugs, including Ozempic, Wegovy, Trulicity and Mounjaro, produced by independent pharmacy ...
PBS

FDA's new expedited drug program raises legal questions and concerns

WASHINGTON (AP) — The Food and Drug Administration commissioner's effort to drastically shorten the review of drugs favored by President Donald Trump's administration is causing alarm across the ...